Resonant
0 followers
‌
Neurodegenerative disorders (NGDs) affect millions worldwide. Starting with Alzheimers, we are committed to creating novel testing solutions for early detection to provide clinicians, researchers, and individuals with the tools to effectively diagnose, treat, and manage NGDs.
Industries
+3
Headquarters
Employees
Links
Org chart
Chad Pollard
Co-Founder & CEO
Chad Pollard
Collapse
Erin Saito
Director, Medical Writing
Tanner Jensen
Director Of Sales
Dean Lilley
Director, Product & Marketing
Renzo Caina
Senior Software Developer
